Impact of Albuminuria on the Prognosis After Transcatheter Aortic Valve Implantation.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 01 2023
Historique:
received: 19 07 2022
revised: 06 09 2022
accepted: 26 09 2022
pubmed: 25 10 2022
medline: 7 12 2022
entrez: 24 10 2022
Statut: ppublish

Résumé

The impact of preoperative albuminuria on the prognosis after transcatheter aortic valve implantation (TAVI) has not been studied. A total of 228 patients who underwent TAVI for severe aortic stenosis (AS) and for whom preoperative urinary data was available were retrospectively investigated. Patients were divided into two groups according to the urinary albumin-to-creatinine ratio (ACR): high (ACR≥ 30 mg/g) and low (ACR<30 mg/g). The urinary total protein-to-creatinine ratio (PCR) and dipstick proteinuria were also evaluated. The primary outcome was the composite outcome of all-cause death and readmission for heart failure. In total, 117 patients had a high ACR and 111 patients had a low ACR. During the median follow-up period of 467 days, patients with a high ACR had a higher incidence of the primary outcome than those with a low ACR (p<0.001). Patients with a high PCR or positive dipstick proteinuria were also at a higher risk for the primary outcome (p<0.001 and p=0.008, respectively). Multivariable Cox proportional hazards analysis showed a high ACR was independently associated with a primary outcome (hazard ratio, 4.98; 95% confidence interval, 1.84-13.49; p=0.002). In conclusion, preoperative albuminuria is an independent predictor of cardiac events in patients with severe AS undergoing TAVI.

Identifiants

pubmed: 36280473
pii: S0002-9149(22)01041-4
doi: 10.1016/j.amjcard.2022.09.020
pii:
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

156-162

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Akihiro Tobe (A)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: tobeakihiro@med.nagoya-u.ac.jp.

Akihito Tanaka (A)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yoshiyuki Tokuda (Y)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yoshinori Shirai (Y)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Tatsuya Miyazaki (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Satoshi Yuhara (S)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Sho Akita (S)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Kenji Furusawa (K)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Hideki Ishii (H)

Department of Cardiology, Gunma University Graduate School of Medicine, Maebashi, Japan.

Masato Mutsuga (M)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Toyoaki Murohara (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH